PILÁTOVÁ, Kateřina, Kristína GREPLOVÁ, Regina DEMLOVÁ, Beatrix BENCSIKOVÁ, Giannoula Lakka KLEMENT and Lenka ZDRAŽILOVÁ DUBSKÁ. Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology. Journal of Hematology & Oncology. LONDON: BIOMED CENTRAL LTD, 2013, vol. 6, No 42, p. 1-8. ISSN 1756-8722. Available from: https://dx.doi.org/10.1186/1756-8722-6-42.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
Authors PILÁTOVÁ, Kateřina (203 Czech Republic, belonging to the institution), Kristína GREPLOVÁ (203 Czech Republic, belonging to the institution), Regina DEMLOVÁ (203 Czech Republic, belonging to the institution), Beatrix BENCSIKOVÁ (703 Slovakia, belonging to the institution), Giannoula Lakka KLEMENT (840 United States of America) and Lenka ZDRAŽILOVÁ DUBSKÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Journal of Hematology & Oncology, LONDON, BIOMED CENTRAL LTD, 2013, 1756-8722.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.933
RIV identification code RIV/00216224:14110/13:00069034
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1186/1756-8722-6-42
UT WoS 000321009900001
Keywords in English Platelet; PF-4; CTAP-III; Cancer; Angiogenesis; IL-8; Inflammation
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 18/4/2014 10:13.
Abstract
With the recent addition of anti-angiogenic agents to cancer treatment, the angiogenesis regulators in platelets are gaining importance. Platelet factor 4 (PF-4/CXCL4) and Connective tissue activating peptide III (CTAP-III) are two platelet-associated chemokines that modulate tumor angiogenesis, inflammation within the tumor microenvironment, and in turn tumor growth. Here, we review the role of PF-4 and CTAP-III in the regulation of tumor angiogenesis; the results of clinical trial using recombinant PF-4 (rPF-4); and the use of PF-4 and CTAP-III as cancer biomarkers.
PrintDisplayed: 6/10/2024 09:14